| INTRODUCTION
Lysosomal storage disorders (LSDs), a varied group of inherited metabolic disorders caused by defects of lysosomal function, are individually rare, but collectively common with the prevalence reported to range from 1 in 1500-7000 live births.
1,2 Their clinical presentation varies widely and some of the common clinical findings include skeletal abnormalities, visceromegaly, and often, features of central nervous system dysfunction, ranging from behavioral abnormalities to severe mental retardation. 1, 3 Recently, the availability of effective treatment options has encouraged the implementation of pilot newborn screening programs for selected LSDs in several developed countries. [4] [5] [6] [7] Enzyme replacement therapy, 1, 8 bone marrow or hematopoietic stem cell transplant, 9 and substrate reduction therapy 10 are some of the available treatment options for these disorders. Early commencement of the appropriate treatment strategy is crucial to prevent irreversible organ damage.
The diagnosis of LSDs is usually performed by assaying the lysosomal enzyme of interest by means of a synthetic or natural substrate, in serum, leukocytes and fibroblasts. Chamoles et al. 11 first demonstrated enzymatic diagnosis of LSDs using dried blood spots (DBS) collected on a filter paper. Later, Li et al. 12 developed a multiplexed MS/MS assay to measure the activities of five lysosomal enzymes in DBS:acid α-glucosidase (GAA), acid α-galactosidase (GLA), acid β-glucocerebrosidase (GBA), acid sphingomyelinase (ASM), and galactocerebrosidase (GALC).
Zhang and co-workers reported the assay for measurement of lysosomal enzymes in DBS in a high-throughput manner suitable for newborn screening laboratories. 13 Given the easy sampling, shipping, and stability of samples, DBS has evident advantages over other sample types.
14 Several pilot studies on newborn screening for single diseases or multiple LSDs with fluorimetric and mass spectrometric methods have been carried out using the DBS technology.
15-19
When conducting tests on DBS, the integrity of the sample is very 
| MATERIALS AND METHODS

| DBS sample preparation
| Effect of drying temperature and storage conditions
In order to test the effect of drying temperature of the DBS on lysosomal enzyme activities, one set of DBS samples from the 12 subjects were placed in racks and dried for 4 hours at 24°C, which is the ambient temperature of an air-conditioned room. This was used as the control. The other DBS samples were kept at 30°C, 37°C, and 45°C for 4 hours each.
To evaluate the effect of DBS storage temperature on stability of enzyme activities, DBS were stored at −80°C, 4°C, 20°C, 30°C, 37°C, and 45°C for 10, 20, 30, 40, and 60 days each. The lysosomal enzymes, GAA, GLA, GBA, ASM, and GALC, were estimated in all DBS specimens by a multiplex assay using electrospray ionization-tandem mass spectrometer (ESI-MS/MS).
| LSD MS/MS Multiplex assay cocktail preparation
Vials containing substrate and internal standard for assaying lysosomal enzymes were obtained from the Centers for Disease Control and Prevention (CDC) foundation (Atlanta, GA, USA). Appropriate buffer and detergent solutions were added to known lyophilized amounts of substrates and internal standards to create specific cocktails. On mixing, aliquots of the cocktails were then stored at −20°C until use.
Quality control samples with low, medium, and high enzyme activities were obtained from CDC foundation.
| Enzyme activity by MS/MS assay
Five enzyme activities were measured using the modification of
Li's multiplex assay by MS/MS as described by Zhang et al. 13 Two 3.2 mm diameter spots were punched from each DBS sample and blank filter paper. The first spot was extracted in 20 mmol/L sodium phosphate buffer for 1 hour at 37°C with shaking on a rocking platform at ~1000 rpm. The DBS extract was then added to GAA, GLA, GBA, or ASM assay cocktail in separate wells. The second spot was added to a well containing GALC assay cocktail. The plates were then sealed with aluminum foil and incubated in a thermo- 
| Fluorescent GAA activity assay
Acid α-glucosidase activity in DBS was measured using a modification of an assay described by Nestor Chamoles et al. 
| Fluorescent GBA activity assay
Acid β-glucocerebrosidase activity in DBS was measured using a modification of an assay described by Nestor Chamoles et al. is calculated by subtracting individual activity with CBE from the activity generated without CBE.
| RESULTS
| Effect of DBS drying temperatures on enzyme activity
Enzyme activities in DBS dried at 30°C, 37°C, and 45°C for 4 hours were compared with control DBS enzyme activities dried at 24°C. The mean activities of all five enzymes significantly decreased when DBS was dried at temperatures above 24°C (P<.0001). While the mean activities in DBS dried at 30°C measured between 66% (GAA) and 83.51% (GALC) of the mean control DBS activities, the mean activities in DBS dried at 37°C measured between 49.25% and 67.6% of the mean control DBS activities. The activities decreased even more when the DBS were exposed to 45°C (31.5%-48.3%). Activities of GAA, GBA, GLA, ASM, and GALC in DBS measured using the MS/MS are shown in Figure 1 .
| Effect of storage conditions on enzyme activity
Effect of different storage conditions on the enzyme activities have been depicted in Figure 2 . Enzyme activities in DBS stored at 4°C, 24°C, 30°C, 37°C, and 45°C for 10, 20, 30, 40, and 60 days were compared with the enzyme activities in DBS samples stored at −80°C. The activity of GAA decreased significantly when stored for 10 days at 4°C (P=.02). It decreased further when kept at higher temperatures for 10 days (P<.0001). Decrease in the activity became highly significant when stored for more than 10 days at temperatures higher than −80°C (P<.0001). Similarly, GBA activity also decreased when stored for 10 days at 4°C (P=.0011). Activity decreased even more at higher temperatures (P<.0001). The decrease in activity was significantly higher when stored for longer duration at higher temperatures (P<.0001). Least activity was observed when kept for 60 days.
Acid sphingomyelinase activity showed comparable results. Lower activity was observed at 4°C, when stored for 10 days (P=.0007).
Activity decreased significantly at higher temperatures (P<.0001), with further decrease when stored for more than 10 days (P<.0001).
Difference in GLA activity was not significant (P=.15) when stored at 4°C for 10 days, compared to activity at −80°C. However, difference was significant when stored at 24°C (P=.03) and 30°C (P=.0003), for 10 days. Lower activity was observed at 37°C and 45°C (P<.0001).
Activity decreased even more when stored for longer duration (P<.0001). Likewise, GALC activity did not show significant difference (P=.35) at 4°C, but it decreased significantly when kept at 24°C and higher temperature (P<.0001), when stored for 10 days. Least activity was observed when stored for longer duration (P<.0001).
Acid α-glucosidase and GBA activities in DBS were also measured using the fluorimetric assay, and the results were compared with that of MS/MS assay ( Figure 3) . We observed no difference in the results of the two methods.
| DISCUSSION
Despite the increasing acceptance of using DBS for analysis of lysosomal enzymes for newborn screening for LSDs, the method has its limitations. Enzyme activities in DBS can be affected by many factors related to blood collection and sample preparation. 7, 24, 25 During DBS preparation, it is vital to dry blood spots completely before trans-
portation. Specifically, a minimum of 3-4 hours drying in an open
space at room temperature is recommended. 26, 27 In India, the ambient temperature is over 30°C during several months in summer.
Our study showed that enzyme activities decreased significantly when DBS was dried at temperatures above 24°C (P<.0001). Our while samples stored at −20°C and 4°C were shown to be stable for 6 months, with minimal loss of enzyme activity. Our study demonstrated that DBS samples stored at temperatures 4°C and above, for 10 days and more, lead to marked loss of enzyme activities. The shorter enzyme stability found in our study could be due to the exposure of the samples to higher relative humidity. We have not employed measures to control humidity when collecting and storing samples, and this is a major limitation of our current study. In India and other humid tropical countries, where the ambient temperature is high, and transport to a central laboratory for analysis may take time, this aspect needs to be taken into account to avoid false positive results. However, storing and transporting the DBS sample in sealed plastic bags with desiccant may preserve the enzyme activity if delay in analysis is anticipated.
Since tandem mass spectrometry and fluorimetry are the widely accepted analytical techniques used in newborn screening, 19 we compared both the methods by determining GAA and GBA activity. We observed no difference in the results of the two methods.
In conclusion, if large scale screening for LSDs is introduced in India or other tropical, developing countries, it is essential to collect and dry blood spots in an air-conditioned room to maintain an ambient temperature of 24°C or less. In addition, the samples need to be transported to the laboratory and analysis carried out within 10 days for obtaining accurate results. 
